Poolbeg Pharma Ltd. (GB:POLB) has released an update.
Poolbeg Pharma Ltd., a biopharmaceutical company, has announced it will voluntarily delist from the OTCQB Market after Monday, 29 July 2024, due to low trading volumes and the administrative overhead involved. The company will maintain its listing on the AIM Market of the London Stock Exchange and continues to eye a future dual listing in the U.S. on an exchange like Nasdaq, once eligibility criteria are met. Poolbeg Pharma remains dedicated to the development of innovative treatments for diseases with significant unmet medical needs.
For further insights into GB:POLB stock, check out TipRanks’ Stock Analysis page.
